MAPT and neurodegenerative disease: 4R tau seeds were characteristic of 4R tauopathies, with occurrence noted in select other cases across neurodegenerative diseases although with a lower prevalence with comparison to 3R/4R tau seeds (Fig. 7 and Supplementary Fig. 5, online resource).